Rheumatology Doctors in Elk Grove Village, IL Accepting Medicare

5 Rheumatology doctors found. Showing 1 - 5

Dina P Dadabhoy, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd, Suite 4003, Elk Grove Village, IL 60007 Phone: 847-364-0800    Fax: 847-364-0858

Glenn I Weiner, DO Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd, Suite 4003, Elk Grove Village, IL 60007 Phone: 847-364-0800    Fax: 847-364-0854

Prerana Panchal, Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 901 Biesterfield Rd, #207, Elk Grove Village, IL 60007 Phone: 847-545-9028

Bruce Johnson, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 800 W Biesterfield Road, Suite 4003, Elk Grove Village, IL 60007 Phone: 847-364-0800    Fax: 847-364-0854

Josna Haritha, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 800 Biesterfield Rd Ste 4003, Elk Grove Village, IL 60007 Phone: 847-364-0800    Fax: 847-364-0808

News Archive

Health Canada approves PRADAX for preventing stroke in AF patients

Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF) in whom anticoagulation is appropriate, marking the second approval of this new oral anticoagulant following the recent marketing authorisation by the US Food and Drug Administration (FDA).

New Department of Health Services Research for quality cancer care

Oncologist and cancer care outcomes researcher Sharon H. Giordano, M.D., leads the new Department of Health Services Research at The University of Texas MD Anderson Cancer Center, a multidisciplinary area of research that examines the delivery, quality and costs of health care.

Ampio updates phase III, multicenter, double-blind STEP study of Ampion for knee osteoarthritis

Ampio Pharmaceuticals, Inc. today announced an update on the phase III, multicenter, double-blind STEP study of Ampion™ for osteoarthritis of the knee.

Epigenomic alterations play key role in triggering obesity-induced diabetes

Obesity is a risk factor for developing type 2 diabetes, yet not all obese humans develop the disease. In a new study, researchers from the Karolinska Institutet in Sweden and from the Institute of Health and Medical Research in France have identified epigenomic alterations that are associated with inflammation and type 2 diabetes

Read more Medical News

› Verified 5 days ago